Catheter-Directed Thrombolysis Versus Pharmacomechanical Thrombectomy for Upper Extremity Deep Venous Thrombosis : A Cost-Effectiveness Analysis

Show full item record



Permalink

http://hdl.handle.net/10138/299878

Citation

Mahmoud , O , Vikatmaa , P , Räsänen , J , Peltola , E , Sihvo , E , Vikatmaa , L , Lappalainen , K & Venermo , M 2018 , ' Catheter-Directed Thrombolysis Versus Pharmacomechanical Thrombectomy for Upper Extremity Deep Venous Thrombosis : A Cost-Effectiveness Analysis ' , Annals of Vascular Surgery , vol. 51 , pp. 246-253 . https://doi.org/10.1016/j.avsg.2018.01.104

Title: Catheter-Directed Thrombolysis Versus Pharmacomechanical Thrombectomy for Upper Extremity Deep Venous Thrombosis : A Cost-Effectiveness Analysis
Author: Mahmoud, O.; Vikatmaa, P.; Räsänen, J.; Peltola, E.; Sihvo, E.; Vikatmaa, L.; Lappalainen, K.; Venermo, M.
Contributor: University of Helsinki, Verisuonikirurgian yksikkö
University of Helsinki, Verisuonikirurgian yksikkö
University of Helsinki, III kirurgian klinikka
University of Helsinki, Department of Diagnostics and Therapeutics
University of Helsinki, III kirurgian klinikka
University of Helsinki, Department of Diagnostics and Therapeutics
University of Helsinki, Department of Diagnostics and Therapeutics
University of Helsinki, Verisuonikirurgian yksikkö
Date: 2018-08
Language: eng
Number of pages: 8
Belongs to series: Annals of Vascular Surgery
ISSN: 0890-5096
URI: http://hdl.handle.net/10138/299878
Abstract: Background: Upper extremity deep vein thrombosis represents (UEDVT) 2-3% of all deep vein thrombosis. Catheter directed thrombolysis (CDT) was replaced largely by pharmacomechanical thrombolysis (PMT) in our institution. In this study we compared the immediate and 1-year results as well as the total hospital costs between CDT and PMT in the treatment of UEDVT. Methods: From 2006 to 2013, 55 patients with UEDVT were treated with either CDT or PMT at Helsinki University Hospital. Of them, 43 underwent thoracoscopic rib resection later to relieve phlebography-confirmed vein compression. This patient cohort was prospectively followed up with repeated phlebographies. CDT was performed to 24 patients, and 19 had PMT with a Trellis (TM) device. Clinical evaluation and vein patency assessment were performed with either phlebography or ultrasound 1 year after the thrombolysis. Primary outcomes were immediate technical success, 1-year vein patency, and costs of the initial treatment. Results: The immediate overall technical success rate, defined as recanalization of the occluded vein and removal of the fresh thrombus, was 91.7% in the CDT group and 100% in the PMT group (n.s.). The median thrombolytic time was significantly longer in CDT patients than that in PMT patients (21.1 vs. 0.33 hr, P <0.00001). There were no procedure-related complications. The 1-year primary assisted patency rate was similar in both the groups (91.7% and 94.7%). There were no recurrences of clinical DVT. The hospital costs for the acute period were significantly lower in the PMT group than those in the CDT group (medians: 11,476 (sic) and 5,975 (sic) in the CDT and PMT groups, respectively [P <0.00001]). Conclusions: The clinical results of the treatment of UEDVT with CDT or PMT were similar. However, PMT required shorter hospital stay and less intensive surveillance, leading to lower total costs.
Subject: PAGET-SCHROETTER-SYNDROME
REGISTRY
RESECTION
SUBCLAVIAN VEIN
THERAPY
VEIN-THROMBOSIS
3126 Surgery, anesthesiology, intensive care, radiology
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
1_s2.0_S0890509618302292_main.pdf 2.265Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record